ARCHIVES

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

This article is from The Cancer Letter archive.

Vol. 19 No. 41 | October 22, 1993

Download PDF Visit The Full Archive

Related Articles

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002